PERKINS CAPITAL MANAGEMENT INC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PERKINS CAPITAL MANAGEMENT INC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$30
-74.1%
13,700
-70.0%
0.03%
-76.1%
Q1 2023$116
+36.5%
45,7000.0%0.11%
+21.1%
Q4 2022$85
-99.9%
45,700
-8.0%
0.09%
-37.1%
Q3 2022$128,000
+33.3%
49,7000.0%0.14%
+44.4%
Q2 2022$96,000
-35.1%
49,7000.0%0.10%
-18.2%
Q1 2022$148,000
-45.2%
49,700
-17.4%
0.12%
-33.5%
Q4 2021$270,000
-27.0%
60,200
-21.0%
0.18%
-20.5%
Q3 2021$370,000
-28.8%
76,2000.0%0.23%
-22.4%
Q2 2021$520,000
-3.0%
76,200
+0.5%
0.30%
-4.8%
Q1 2021$536,00075,8500.31%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders